Skip to main content
AstraZenecaFacility expansion

AstraZeneca opens new global strategic R&D centre in Kendall Square, Cambridge, Massachusetts

Source: Autobound Signal API · 80 signals tracked for AstraZeneca · updated

Get AstraZeneca's live signals in Claude or ChatGPT, or by API

AskWhat changed at AstraZeneca this week? Use Autobound signals for astrazeneca.com.

What happened

AstraZeneca opened a new global strategic research and development (R&D) centre in Kendall Square, Cambridge, Massachusetts, representing a $1 billion investment.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

$1 billion investment will grow AstraZeneca's workforce in Massachusetts by over 50% and deliver next-generation medicines. AstraZeneca today announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts. The new state-of-the-art facility builds on the Company's existing presence in Cambridge and Boston and places its scientists at the heart of one of the world's most innovative life sciences ecosystems. Together with its site for genomic medicine at 100 Binney Street, The AstraZeneca R&D Center Kendall Square will be home to nearly 2,000 world-class researchers and scientists who will accelerate the Company's oncology, cell therapy, chronic disease and rare disease pipeline to deliver transformative medicines of the future. The 570,000 square foot, 18 story site at 290 Binney Street is designed to enhance collaboration and was built with the highest standards of sustainable design to minimize our impact on the planet. The R&D centre includes ten floors of interconnecting laboratories to allow a flow of seamless science enabled by cutting-edge technologies that integrate robotics, continuous automation, and agentic AI. Leading experts will deliver novel treatments from our pipeline to treat people struggling to live with diseases such as COPD, obesity and metabolic disease, breast cancer and rare...

Keep reading with a free account

The rest of this article, and every signal for AstraZeneca, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Facility expansion

What this signalsA bigger facility often needs new equipment, systems and services.

Amount named
$1B
Takes effect
Oct 5, 2026
Location
Cambridge, Massachusetts, United States

More facility expansion signals at other companies

The full record

From the Signal API record

Numbers

Amount named in the story
$1B

Details

Assets
global strategic research and development (R&D) centre

Topics and mentions

Asset tags

  • research and development

Extraction

Confidence
95%
Detected
Oct 5, 2026
signal_type
news
signal_subtype
expands_facilities

Use this data

Get every facility expansion signal for AstraZeneca and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AstraZeneca this week?”

  2. Send it to your own tools

    The Signal API returns facility expansion signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/4164be3b-24df-518f-36dd-8deeebdd3f47 returns this record as JSON. POST /v1/companies/enrich returns every signal for astrazeneca.com.

{
  "signal_id": "4164be3b-24df-518f-36dd-8deeebdd3f47",
  "signal_type": "news",
  "signal_subtype": "expands_facilities",
  "detected_at": "2026-10-05T16:11:00+00:00",
  "company": {
    "name": "AstraZeneca",
    "domain": "astrazeneca.com"
  },
  "data": {
    "url": "https://news.cision.com/se/astrazeneca/r/astrazeneca-opens-new-global-strategic-r-d-centre-in-kendall-square--cambridge--massachusetts,c4404837",
    "title": "AstraZeneca opens new global strategic R&D centre in Kendall Square, Cambridge, Massachusetts - Cision News",
    "assets": "global strategic research and development (R&D) centre",
    "excerpt": "$1 billion investment will grow AstraZeneca’s workforce in Massachusetts by over 50% and deliver next-generation medicines. AstraZeneca today announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts. The new state-of-the-art facility builds on the Company’s existing presence in Cambridge and Boston and places its scientists at the heart of one of the world’s most innovative life sciences ecosystems. Together with its site for genomic medicine at 100 Binney Street, The AstraZeneca R&D Center Kendall Square will be home to nearly 2,000 world-class researchers and scientists who will accelerate the Company’s oncology, cell therapy, chronic disease and rare disease pipeline to deliver transformative medicines of the future. The 570,000 square foot, 18 story site at 290 Binney Street is designed to enhance collaboration and was built with the highest standards of sustainable design to minimize our impact on the planet. The R&D centre includes ten floors of interconnecting laboratories to allow a flow of seamless science enabled by cutting-edge technologies that integrate robotics, continuous automation, and agentic AI. Leading experts will deliver novel treatments from our pipeline to treat people struggling to live with diseases such as COPD, obesity and metabolic disease, breast cancer and rare...",
    "summary": "AstraZeneca opened a new global strategic research and development (R&D) centre in Kendall Square, Cambridge, Massachusetts, representing a $1 billion investment.",
    "location": "Kendall Square, Cambridge, Massachusetts, USA",
    "planning": false,
    "image_url": "https://mb.cision.com/Public/309/4404837/af03032e0eb9b1d3_400x400ar.jpg",
    "confidence": 0.95,
    "assets_tags": [
      "research_and_development"
    ],
    "published_at": "2026-10-05T16:11:00Z",
    "location_data": [
      {
        "city": "Cambridge",
        "state": "Massachusetts",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-10-05",
    "article_sentence": "AstraZeneca today announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts.",
    "amount_normalized": 1000000000
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.